Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 2/20 | 0.67 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL23199870 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL14856129 | 0.95 | — | — | |
| Sulfuric Acid SCHEMBL27665155 | 0.95 | — | — | |
| Sulfuric Acid SCHEMBL28717292 | 0.95 | CA5A (0.60) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL28671639 | 0.95 | — | — | |
| Sulfuric Acid SCHEMBL9221359 | 0.95 | CA5A (0.60) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL980233 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL8648622 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL62672 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL980129 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140155282-A1 | METHODS OF DETERMINING STABILIZATION COMPOUNDS FOR PREDICTIVE BIOMARKERS | COMPANION DIAGNOSTICS, INC. (US) | 2014-06-05 | — | — | US | disclosed |
| US-8574856-B2 | Methods for determining the efficiency of a therapeutic | COMPANION DIAGNOSTICS INC. (US) | 2013-11-05 | — | — | US | disclosed |
| US-8501669-B2 | Systems and methods of screening biomarkers in bodily fluids | COMPANION DIAGNOSTICS INC. (US) | 2013-08-06 | — | — | US | disclosed |
| US-20130184186-A1 | SYSTEMS AND METHODS FOR THE DETECTION OF BIOMARKERS | COMPANION DIAGNOSTICS INC. (US) | 2013-07-18 | — | — | US | disclosed |
| US-20130184187-A1 | SYSTEMS AND METHODS FOR BIOMARKER ANALYSIS | COMPANION DIAGNOSTICS INC. (US) | 2013-07-18 | — | — | US | disclosed |
| US-20130157373-A1 | SYSTEMS AND METHODS FOR HEMOGLOBIN ANALYSIS | COMPANION DIAGNOSTICS INC. (US) | 2013-06-20 | — | — | US | disclosed |
| US-8426151-B2 | Systems and methods for the detection of biomarkers | COMPANION DIAGNOSTICS INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-8318641-B2 | Systems and methods for the detection of biomarkers | BMO HARRIS BANK N.A. | 2012-11-27 | — | — | US | disclosed |
| US-8318105-B2 | Systems and methods for biomarker analysis | BMO HARRIS BANK N.A. | 2012-11-27 | — | — | US | disclosed |
| US-8293537-B2 | Systems and methods for hemoglobin analysis | BMO HARRIS BANK N.A. | 2012-10-23 | — | — | US | disclosed |
| US-20110195491-A1 | DEVICES AND SYSTEMS FOR BIOMARKER DETECTION | BMO HARRIS BANK N.A. | 2011-08-11 | — | — | US | disclosed |
| US-20110195397-A1 | DRINK MIXTURE FOR THE STABILIZATION OF DIAGNOSTIC BIOMARKERS | BMO HARRIS BANK N.A. | 2011-08-11 | — | — | US | disclosed |
| US-20110195859-A1 | SYSTEMS AND METHODS FOR THE DETECTION OF BIOMARKERS | BMO HARRIS BANK N.A. | 2011-08-11 | — | — | US | disclosed |
| US-20110195439-A1 | SYSTEMS AND METHODS FOR DETERMINING CARDIAC CONDITIONS | BMO HARRIS BANK N.A. | 2011-08-11 | — | — | US | disclosed |
| US-20110195403-A1 | SYSTEMS AND METHODS FOR FERTILITY ANALYSIS | BMO HARRIS BANK N.A. | 2011-08-11 | — | — | US | disclosed |
| US-20110195423-A1 | SYSTEMS AND METHODS FOR DIAGNOSING BACTERIAL INFECTIONS | BMO HARRIS BANK N.A. | 2011-08-11 | — | — | US | disclosed |
| US-20110195394-A1 | SYSTEMS AND METHODS FOR DIAGNOSING VIRAL INFECTIONS | BMO HARRIS BANK N.A. | 2011-08-11 | — | — | US | disclosed |
| US-20110195398-A1 | SYSTEMS AND METHODS FOR DETECTING INSULIN RESISTANCE BIOMARKERS | BMO HARRIS BANK N.A. | 2011-08-11 | — | — | US | disclosed |
| US-20110195404-A1 | SYSTEMS AND METHODS FOR DETERMINING CALCIUM LEVELS | BMO HARRIS BANK N.A. | 2011-08-11 | — | — | US | disclosed |
| US-20110195402-A1 | SYSTEMS AND METHODS FOR DETECTING DRUG USE | BMO HARRIS BANK N.A. | 2011-08-11 | — | — | US | disclosed |